The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
August 29, 2018
Abstract : Huadong Medicine Co. announced on Wednesday that its wholly-owned sub-subsidiary Huadong Medicine Aesthetics Investment (HongKong) Limited planned to acquire a 100 percent stake in Sinclair Pharma plc.
BEIJING, Aug.29 (Xinhua) -- Huadong Medicine Co.,Ltd. (000963.SZ) announced on Wednesday that its wholly-owned sub-subsidiary Huadong Medicine Aesthetics Investment (HongKong) Limited planned to acquire a 100 percent stake in Sinclair Pharma plc,a UK-based aesthetic and medical company, for about 1.5 billion yuan, the Xinhua-run cnstock.com reported.
According to the announcement, the offer is likely to be made in cash.
(Edited by Yang Yifan, yangyifan@xinhua.org)
Keyword: China-medical Huadong-Medicine
Most Read
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
A single purchase
